Cystic fibrosis boost from Queen's University in Belfast
A leading doctor from Queen's University in Belfast has played a major role in research that could improve the lives of cystic fibrosis sufferers.
Professor Stuart Elborn, regarded an international authority in respiratory medicine, led the pivotal studies of a new treatment which he described as a "significant breakthrough". The combination therapy improves lung function and reduces hospitalisations for patients with the most common type of cystic fibrosis, the fatal lung disease.
Prof Elborn worked alongside colleagues from the United States and Australia on the study, involving over 1,100 patients worldwide.
There are about 500 people living with CF in Northern Ireland
Prof Elborn, Dean of the School of Medicine, Dentistry and Biomedical Sciences, said: "This has the potential to help roughly half of those with cystic fibrosis."